Ying Zhang

Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial

Mark C. Genovese, Roy Fleischmann, Bernard Combe et al. · The Lancet · 2018 · 415 citations

Rheumatoid Disorder, Rheumatology, Anti-inflammatory +9

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Josef S Smolen, Aileen L. Pangan, Paul Emery et al. · The Lancet · 2019 · 348 citations

Rheumatoid Disorder, Rheumatology, Double-blind Phase 3 +10

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

Andrea Rubbert‐Roth, Jeffrey Enejosa, Aileen L. Pangan et al. · New England Journal of Medicine · 2020 · 281 citations

Activated macrophage-targeted dextran–methotrexate/folate conjugate prevents deterioration of collagen-induced arthritis in mice

Modi Yang, Jianxun Ding, Ying Zhang et al. · Journal of Materials Chemistry B · 2016 · 83 citations

Free Mtx, Immunology, Inflammatory Arthritis +19

RNA-seq reveals the circular RNA and miRNA expression profile of peripheral blood mononuclear cells in patients with rheumatoid arthritis

Jianting Wen, Jian Liu, Pingheng Zhang et al. · Bioscience Reports · 2020 · 58 citations · Full text